D Goldstein

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. ncbi request reprint An educational workshop program for rural practitioners to encourage best practice for delivery of systemic adjuvant therapy
    Lauren Dalton
    Support Scheme for Rural Specialists, Sydney, New South Wales, Australia
    J Cancer Educ 21:35-9. 2006
  2. pmc Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study
    David Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia
    BMC Cancer 6:240. 2006
  3. doi request reprint Solitary extramedullary plasmacytoma of the head and neck--long-term outcome analysis of 68 cases
    Gideon Bachar
    Department of Otolaryngology Head and Neck Surgery, Princess Margaret Hospital, Toronto, Canada
    Head Neck 30:1012-9. 2008
  4. doi request reprint Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?
    David K Chang
    Upper Gastrointestinal Surgery Unit, Bankstown Hospital, Bankstown, Australia
    J Gastroenterol Hepatol 23:1036-45. 2008
  5. doi request reprint Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study
    David Goldstein
    Prince of Wales Hospital, Randwick, Australia
    J Clin Oncol 30:1805-12. 2012
  6. pmc When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis
    Chee Khoon Lee
    Department of Medical Oncology, Prince of Wales Hospital, NSW, Australia
    World J Surg Oncol 7:8. 2009
  7. pmc Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29
    Junjie Peng
    Department of Colorectal Surgery, Cancer Hospital Fudan University, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    Radiat Oncol 6:93. 2011
  8. ncbi request reprint Phase II study of vinflunine in patients with metastatic renal cell carcinoma
    D Goldstein
    Prince of Wales Hospital, Randwick, Australia
    Invest New Drugs 24:429-34. 2006
  9. doi request reprint Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
    David Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW, Australia
    Cancer Chemother Pharmacol 67:519-25. 2011
  10. pmc Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Randwick, Sydney, NSW 2031, Australia
    Br J Cancer 92:832-7. 2005

Collaborators

Detail Information

Publications84

  1. ncbi request reprint An educational workshop program for rural practitioners to encourage best practice for delivery of systemic adjuvant therapy
    Lauren Dalton
    Support Scheme for Rural Specialists, Sydney, New South Wales, Australia
    J Cancer Educ 21:35-9. 2006
    ..The Rural Systemic Adjuvant Therapy Project was initiated to encourage best practice in the treatment of women from rural areas who have breast cancer...
  2. pmc Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study
    David Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia
    BMC Cancer 6:240. 2006
    ..We sought to examine the longitudinal relationships between fatigue and mood disorder in women treated with adjuvant therapy for early stage breast cancer...
  3. doi request reprint Solitary extramedullary plasmacytoma of the head and neck--long-term outcome analysis of 68 cases
    Gideon Bachar
    Department of Otolaryngology Head and Neck Surgery, Princess Margaret Hospital, Toronto, Canada
    Head Neck 30:1012-9. 2008
    ..Head and neck solitary extramedullary plasmacytomas are rare plasma cell neoplasms. Literature review reveals only small numbers of reports. The objective was to review our experience with treating patients with this neoplasm...
  4. doi request reprint Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?
    David K Chang
    Upper Gastrointestinal Surgery Unit, Bankstown Hospital, Bankstown, Australia
    J Gastroenterol Hepatol 23:1036-45. 2008
    ....
  5. doi request reprint Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study
    David Goldstein
    Prince of Wales Hospital, Randwick, Australia
    J Clin Oncol 30:1805-12. 2012
    ..Hence, relationships to cancer, surgery, and adjuvant therapy are unclear...
  6. pmc When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis
    Chee Khoon Lee
    Department of Medical Oncology, Prince of Wales Hospital, NSW, Australia
    World J Surg Oncol 7:8. 2009
    ..A number of non-malignant diseases that share similar morphological features as gastrointestinal stromal tumor (GIST) have been reported. Co-existence of GIST with these other diseases is rarely recognized or reported...
  7. pmc Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29
    Junjie Peng
    Department of Colorectal Surgery, Cancer Hospital Fudan University, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    Radiat Oncol 6:93. 2011
    ..To assess the quality of life in curatively treated patients with rectal cancer in a prospectively collected cohort...
  8. ncbi request reprint Phase II study of vinflunine in patients with metastatic renal cell carcinoma
    D Goldstein
    Prince of Wales Hospital, Randwick, Australia
    Invest New Drugs 24:429-34. 2006
    ..An open-label, multicentre, non-comparative phase II trial to determine the response rate of intravenous vinflunine as first line chemotherapy in patients with metastatic renal cell carcinoma (RCC)...
  9. doi request reprint Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
    David Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW, Australia
    Cancer Chemother Pharmacol 67:519-25. 2011
    ..Biliary tract cancers (BTC) have a poor prognosis, and there is no consensus on the best chemotherapy regimen. This study determined the response rate for fixed-dose-rate (FDR) gemcitabine combined with cisplatin...
  10. pmc Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Randwick, Sydney, NSW 2031, Australia
    Br J Cancer 92:832-7. 2005
    ..Median progression-free survival was 8.2 months (7.1-9.9) and median overall survival was 18.7 months (14.0-23.4). In our experience, a modified schedule of FOLFOX improves convenience without compromising efficacy or toxicity...
  11. ncbi request reprint Modern management of pancreatic carcinoma
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, New South Wales, Australia
    Intern Med J 34:475-81. 2004
    ..Chemotherapy with gemcitabine has modest objective response rates but has been shown to improve symptoms...
  12. ncbi request reprint Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study
    David Goldstein
    Department of Medical Oncology, Prince of Wales Hospital and University of New South Wales, Sydney, Australia
    Oncology 69:326-32. 2005
    ....
  13. ncbi request reprint Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    J Infect Dis 178:858-61. 1998
    ..Imiquimod induced pronounced levels of circulating interferon in asymptomatic HIV-infected persons, with variable effect on virus load...
  14. pmc The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, High Street, Randwick, New South Wales 2031, Australia
    Br J Cancer 106:61-9. 2012
    ....
  15. pmc Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
    W Chua
    Department of Medical Oncology, Sydney Cancer Centre, Concord Repatriation General Hospital, Sydney, NSW, Australia
    Br J Cancer 101:998-1004. 2009
    ....
  16. pmc Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Barker Street, Randwick, New South Wales 2031, Australia
    Br J Cancer 97:464-71. 2007
    ..This approach to treatment of locally advanced pancreatic cancer is safe and promising, with good local control for a substantial proportion of patients, and merits testing in a randomised trial...
  17. doi request reprint Prognostic communication preferences of migrant patients and their relatives
    D Mitchison
    School of Psychology, University of Sydney, Sydney, NSW, Australia
    Psychooncology 21:496-504. 2012
    ....
  18. ncbi request reprint Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach
    M L Harrison
    Department of Medical Oncology, Prince of Wales Hospital, New South Wales, Australia
    Intern Med J 36:367-77. 2006
    ..Many of the strategies used are likely to be widely applicable to the use of targeted therapies in other malignancies...
  19. doi request reprint Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity
    Susanna B Park
    Prince of Wales Medical Research Institute, Barker St, Randwick, Sydney, New South Wales 2031
    J Clin Oncol 27:1243-9. 2009
    ..Because the mechanism of oxaliplatin-induced neurotoxicity remains unclear, the present study investigated the potential of axonal excitability techniques in identifying pathophysiologic mechanisms and early markers of nerve dysfunction...
  20. ncbi request reprint Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience
    G Marx
    Department of Medical Oncology, Prince of Wales Hospital and Sydney Haematology and Oncology Clinics, Sydney, New South Wales, Australia
    Intern Med J 35:34-8. 2005
    ..We report the feasibility of administering a combination of interferon alpha, subcutaneous interleukin-2 and 5Fluorouracil in the outpatient setting to patients with metastatic renal cell cancer...
  21. ncbi request reprint Oxaliplatin-induced neurotoxicity and the development of neuropathy
    Arun V Krishnan
    Institute of Neurological Sciences, Prince of Wales Hospital, Sydney, NSW, Australia
    Muscle Nerve 32:51-60. 2005
    ..Differences in nerve excitability measures, particularly refractoriness, support in vitro studies indicating involvement of voltage-gated transient Na+-channel dysfunction in the development of oxaliplatin-induced neurotoxicity...
  22. doi request reprint Post-cancer fatigue is not associated with immune activation or altered cytokine production
    B A Cameron
    Infection and Inflammation Research Centre, School of Medical Sciences, University of New South Wales, Sydney, Australia
    Ann Oncol 23:2890-5. 2012
    ..This study investigated the association between cytokine levels and fatigue from the time of treatment to 12 months later...
  23. doi request reprint Management of metastatic renal cell carcinoma in the era of targeted therapies
    K Webber
    Department of Medical Oncology, Prince of Wales Hospital, University of New South Wales, Sydney, Australia
    Intern Med J 41:594-605. 2011
    ..Therapeutic targeting of molecular pathways for tumour angiogenesis and other specific activation mechanisms offers improved tumour response and prolonged survival...
  24. ncbi request reprint Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer
    B Thewes
    Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales 2031, Australia
    J Clin Oncol 23:5155-65. 2005
    ..This multicenter study aimed to investigate fertility- and menopause-related information needs among young women with a diagnosis of early-stage breast cancer...
  25. ncbi request reprint Fatigue and psychological distress--exploring the relationship in women treated for breast cancer
    B Bennett
    Department of Medical Oncology, Prince of Wales Hospital, High Street, Sydney, NSW 2031, Australia
    Eur J Cancer 40:1689-95. 2004
    ..8 vs. 17.8, P = 0.79). Thus the recent emphasis on recording fatigue during and following treatments for cancer needs to be accompanied by concurrent measurement of psychological symptoms...
  26. pmc Cultural aspects of cancer genetics: setting a research agenda
    B Meiser
    Department of Psychological Medicine, Block 4, Level 5, Royal North Shore Hospital, St Leonards, NSW 2065, Sydney, Australia
    J Med Genet 38:425-9. 2001
    ....
  27. ncbi request reprint Oxaliplatin and axonal Na+ channel function in vivo
    Arun V Krishnan
    Institute of Neurological Sciences, Prince of Wales Hospital, Sydney, New South Wales, Australia
    Clin Cancer Res 12:4481-4. 2006
    ..The aim of the study was to investigate the pathophysiology of oxaliplatin-induced neurotoxicity using clinical nerve excitability techniques that provide information about axonal ion channel function...
  28. ncbi request reprint Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines
    Jia Lin Yang
    Oncology Research Centre, Prince of Wales Hospital, Sydney, Australia
    Oncology 69:224-38. 2005
    ..We aimed to determine the effect of combining IFN alpha and gefitinib on colon cancer cell line growth...
  29. ncbi request reprint Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha
    Jia Lin Yang
    Oncology Research Centre, Prince of Wales Hospital, Department of Clinical Medicine, University of New South Wales, Sydney, Australia
    BJU Int 99:1539-45. 2007
    ....
  30. doi request reprint Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
    Susanna B Park
    Prince of Wales Medical Research Institute, Barker Street, Randwick, Sydney, NSW 2031, Australia
    Brain 132:2712-23. 2009
    ..05) than those left with mild or moderate neurotoxicity, suggesting that assessment of sensory excitability parameters may provide a sensitive biomarker of severity for oxaliplatin-induced neurotoxicity...
  31. ncbi request reprint Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines
    Jia Lin Yang
    Department of Surgery and Surgical Oncology Research Group, Prince of Wales Clinical School, University of New South Wales, Barker Street, Randwick, Sydney, NSW 2031, Sydney, Australia
    Cancer Lett 225:61-74. 2005
    ..This approach may have clinical implications for improving treatment based on targeting of HER1/EGFR...
  32. ncbi request reprint Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?
    Louise Shepherd
    Counselling Service, University of New South Wales, East Wing, Quadrangle Building, Kensington Campus, Sydney NSW 2052, Australia
    Aust Health Rev 32:423-38. 2008
    ..Where no face-to-face psychological service exists, these technologies are promising, yet unproven. Less variable methods are needed to better assess the technology and therapeutic approach for stronger evidence...
  33. ncbi request reprint Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians
    Maurice Eisenbruch
    Centre for Culture and Health, University of New South Wales, New South Wales 2052, Australia
    Soc Sci Med 59:235-48. 2004
    ..Further ethnographic studies are needed, focusing on the Chinese groups who do not attend the clinic and those with lower acculturation and educational levels...
  34. ncbi request reprint Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia
    M C Robotin
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
    HIV Med 5:377-84. 2004
    ..To analyse clinical features and predictors of survival for AIDS-related non-Hodgkin's lymphoma (NHL) in the era of highly active antiretroviral therapy (HAART), compared to earlier in the HIV epidemic...
  35. ncbi request reprint Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies
    S B Park
    Prince of Wales Medical Research Institute, Barker Street, Randwick, Sydney, NSW 2031, Australia
    Curr Med Chem 15:3081-94. 2008
    ....
  36. pmc Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing
    K Pryor
    Centre for Immunology, St Vincent s Hospital, Sydney, NSW, Australia
    Br J Cancer 71:801-7. 1995
    ..No synergy occurred between BCG and cytokines at the concentrations tested. The results suggest that BCG is superior to IFN-alpha, interferon gamma (IFN-gamma) and IL-2 in enhancing cell-mediated cytotoxicity...
  37. ncbi request reprint Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells
    M V Apte
    Pancreatic Research Group, Department of Gastroenterology, Bankstown Lidcombe and Liverpool Hospitals, NSW, Sydney, Australia
    Pancreas 29:179-87. 2004
    ....
  38. doi request reprint Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity
    Susanna B Park
    Prince of Wales Medical Research Institute and Prince of Wales Clinical School, Sydney, NSW, Australia
    Oncology 77:342-8. 2009
    ..Limited cases have been described previously and the pathophysiology underlying Lhermitte's phenomenon in oxaliplatin-treated patients has not been established...
  39. ncbi request reprint Communicating in a multicultural society. II: Greek community attitudes towards cancer in Australia
    D Goldstein
    Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia
    Intern Med J 32:289-96. 2002
    ..Open and full disclosure of information regarding diagnosis and prognosis is the prevailing approach to cancer patients. However, such a view appears contrary to the preferences of many ethnic groups in Australia...
  40. ncbi request reprint Alpha-interferon 2a and 1 3-cis-retinoic acid for the treatment of metastatic renal cell carcinoma
    M Wong
    Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia
    Intern Med J 32:158-62. 2002
    ..It is suggested that immunotherapy may have a better role than cytotoxic chemotherapy in the treatment of metastatic renal cell carcinoma...
  41. doi request reprint Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
    N C Tebbutt
    Department of Medical Oncology, Austin Health, Melbourne, Australia
    Ann Oncol 22:1834-8. 2011
    ..Bevacizumab is an antiangiogenic mAb with efficacy against several cancers, but it is associated with risk of arterial thromboembolism (ATE). Further data are needed to determine the safety of bevacizumab...
  42. ncbi request reprint Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy
    Stephen Clarke
    Department of Medical Oncology, Royal Prince Alfred Hospital Sydney Cancer Centre, Sydney, Australia
    Clin Colorectal Cancer 6:578-82. 2007
    ..This analysis assesses the efficacy and safety of a modified FOLFOX (oxaliplatin/leucovorin [LV]/5-fluorouracil [5-FU]) regimen given with a low dose of LV...
  43. ncbi request reprint The utility of videoconferencing to provide innovative delivery of psychological treatment for rural cancer patients: results of a pilot study
    Louise Shepherd
    Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia
    J Pain Symptom Manage 32:453-61. 2006
    ..01) and quality of life (P=0.04). The service was both practical and acceptable. These preliminary positive results provide a firm basis to conduct a randomized controlled trial of face-to-face interaction vs. videoconferencing...
  44. ncbi request reprint Understanding community beliefs of Chinese-Australians about cancer: initial insights using an ethnographic approach
    Soo See Yeo
    Centre for Culture and Health, University of New South Wales, NSW 2052, Sydney, Australia
    Psychooncology 14:174-86. 2005
    ....
  45. doi request reprint Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?
    Prunella Blinman
    NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
    Eur J Cancer 46:1800-7. 2010
    ....
  46. doi request reprint Unmet needs in immigrant cancer survivors: a cross-sectional population-based study
    P N Butow
    Psycho oncology Co operative Research Group PoCoG, University of Sydney, Sydney, NSW, Australia
    Support Care Cancer 21:2509-20. 2013
    ..This study aimed to document unmet needs, and variables associated with these, in a population-based sample of first-generation immigrants and Anglo-Australians who had survived cancer...
  47. pmc Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha
    J L Yang
    Department of Surgery, Prince of Wales Hospital, University of New South Wales, Sydney, Australia
    Gut 53:123-9. 2004
    ....
  48. ncbi request reprint Castleman's disease and HIV infection in Australia
    S Loi
    Department of Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A becket Street, East Melbourne, Victoria 8006, Australia
    HIV Med 5:157-62. 2004
    ..To describe, retrospectively, the Australian experience of multi-centric Castleman's disease (MCD) in the setting of HIV infection, specifically with the advent of HAART, and newer chemotherapeutic agents...
  49. doi request reprint A randomized controlled trial of a standardized educational intervention for patients with cancer pain
    Melanie R Lovell
    Greenwich Hospital, Greenwich, New South Wales, Australia
    J Pain Symptom Manage 40:49-59. 2010
    ..Published literature has not defined the effectiveness of standardized educational tools that can be self-administered in the general oncology population with pain...
  50. ncbi request reprint The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study
    Barbara Bennett
    Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia
    J Pain Symptom Manage 34:126-35. 2007
    ..Qualitatively, CRF appears closely related to CFS. These findings raise the emergent hypothesis of a conserved neurobehavioral symptom complex, which results from diverse triggering insults...
  51. ncbi request reprint Education and role modelling for clinical decisions with female cancer patients
    Rhonda F Brown
    Medical Psychology Research Unit, University of Sydney, Sydney, NSW, Australia
    Health Expect 7:303-16. 2004
    ..This randomized trial investigates the effects of providing cancer patients with a package designed to facilitate shared decision-making prior to seeing their oncologist...
  52. doi request reprint Pancreatic stellate cells: partners in crime with pancreatic cancer cells
    Alain Vonlaufen
    Pancreatic Research Group, South Western Sydney Clinical School, The University of New South Wales, Sydney, New South Wales 2052, Australia
    Cancer Res 68:2085-93. 2008
    ..Our studies indicate a significant interaction between pancreatic cancer cells and stromal cells (PSCs) and imply that pancreatic cancer cells recruit stromal cells to establish an environment that promotes cancer progression...
  53. doi request reprint Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance
    Alain Vonlaufen
    Pancreatic Research Group, South Western Sydney Clinical School and School of Medical Sciences Pathology, The University of New South Wales and Sydney, Sydney, NSW, Australia
    Cancer Res 68:7707-10. 2008
    ..Characterization of the mechanisms mediating PSC-cancer interactions will lead to the development of much needed alternative therapeutic approaches to improve disease outcome...
  54. ncbi request reprint Cancer patient preferences for communication of prognosis in the metastatic setting
    Rebecca G Hagerty
    Medical Psychology Research Unit and Department of Medicine, University of Sydney, Sydney, New South Wales, Australia
    J Clin Oncol 22:1721-30. 2004
    ..To identify preferences for and predictors of prognostic information among patients with incurable metastatic cancer...
  55. ncbi request reprint Multicentric Castleman's disease treated with antivirals and immunosuppressants
    Sanjaya Senanayake
    Department of Infectious Diseases, Prince of Wales Hospital, Barker Street, Randwick, New South Wales 2031, Australia
    J Med Virol 71:399-403. 2003
    ..Despite the implication of HHV-8 as a cause of MCD, few studies have correlated HHV-8 levels with clinical response...
  56. pmc A serious complication of selected internal radiation therapy: case report and literature review
    Katrin M Sjoquist
    Department of Medical Oncology, Prince of Wales Hospital, High Street, Randwick, NSW Australia
    Oncologist 15:830-5. 2010
    ..The characteristic endoscopic, radiologic, and histopathologic findings are illustrated and recommendations are reviewed with regard to the current literature...
  57. ncbi request reprint Clinical supervision and education via videoconference: a feasibility project
    Kristina Xavier
    Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW, Australia
    J Telemed Telecare 13:206-9. 2007
    ..3 out of 10). With regard to telephone supervision, most (80%) were very or extremely satisfied. The feedback indicated that remote supervision was well received and that participants were keen to continue their involvement...
  58. pmc Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases
    Peter S Grimison
    Institute of Oncology, Prince of Wales Hospital, Sydney, Australia
    BMC Cancer 6:117. 2006
    ..Symptoms, imaging and tumour markers can mimic pancreatic adenocarcinoma, but they are much more amenable to treatment. Treatment for PPL remains controversial, particularly the role of surgical resection...
  59. ncbi request reprint Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial
    Martin R Stockler
    NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia
    Lancet Oncol 8:603-12. 2007
    ..We aimed to identify the effects of an established antidepressant on these symptoms and survival in patients with advanced cancer who did not have major depression as assessed by clinicians...
  60. ncbi request reprint Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment
    Xian Jun Qu
    Department of Pharmacology, College of Pharmacy, Shandong University, Jinan, People s Republic of China
    J Urol 172:733-8. 2004
    ....
  61. ncbi request reprint Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity
    Paul L Mitchell
    Austin Hospital, Heidelberg, Melbourne, Australia E mail
    Clin Colorectal Cancer 6:146-51. 2006
    ..Sensory neurotoxicity is dose limiting for oxaliplatin, an effective drug in the treatment of colorectal cancer (CRC) and other malignancies. This study assessed the impact of gabapentin on oxaliplatin dose intensity and neurotoxicity...
  62. pmc Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report
    Brett Hughes
    Medical Oncology Unit, Canberra Hospital, Yamba Drive, Garran, ACT, Australia
    BMC Cancer 4:74. 2004
    ..We describe the case of a man with metastatic GIST who experienced multiple cerebral relapses of disease while systemic disease progression appeared to be controlled by imatinib...
  63. ncbi request reprint Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians
    Kristine Barlow-Stewart
    Center for Genetics Education, Bldg 36, Royal North Shore Hospital, St Leonards, NSW 2065, Australia
    Genet Med 8:24-32. 2006
    ..In societies such as Australia with a strong multicultural makeup, culturally determined attitudes to genetics, testing, and counseling may be incompatible with current genetics service provision...
  64. ncbi request reprint Remoteness of residence and survival from cancer in New South Wales
    Katharine E Jong
    Northern Rivers University Department of Rural Health, University of Sydney, PO Box 3074, Lismore, NSW
    Med J Aust 180:618-22. 2004
    ..To analyse cancer survival in New South Wales by geographic remoteness...
  65. ncbi request reprint Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience
    Brett G M Hughes
    Medical Oncology Unit, The Canberra Hospital, Canberra, ACT, Australia
    ANZ J Surg 74:951-6. 2004
    ..This protocol has not been widely adopted in Australian centres because of perceived risks of toxicity...
  66. ncbi request reprint Compression of liver parenchyma by a malignant hepatic cyst: a previously unreported manifestation of metastatic gastric cancer
    Robert Jones
    Am J Gastroenterol 98:1211-3. 2003
  67. ncbi request reprint Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour
    Florian Grimpen
    Medical Oncology Unit, Canberra Hospital, Garran, Australia
    Lancet Oncol 6:724-7. 2005
  68. ncbi request reprint Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Grou
    Martine van Glabbeke
    European Organisation for Research and Treatment of Cancer Data Center, Av E Mounier, 83, Bte 8, B1200 Brussels, Belgium
    J Clin Oncol 23:5795-804. 2005
    ..This study is based on the European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group randomized trial comparing two doses of imatinib in advanced disease...
  69. ncbi request reprint Inequity in rural cancer survival in Australia is not an insurmountable problem
    Craig R Underhill
    Med J Aust 185:479-80. 2006
  70. ncbi request reprint Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil count
    Michael Michael
    Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Victoria, 8006, Australia
    Clin Colorectal Cancer 6:297-304. 2006
    ..The aim of this study was to identify prognostic indicators of survival and response in a homogeneous population of chemotherapy-naive patients treated with oxaliplatin as part of 3 successive trials...
  71. doi request reprint A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer
    Craig Underhill
    Border Medical Oncology, Wodonga, Vic, USA
    Oncology 73:9-20. 2007
    ..Secondary objectives included overall and progression-free survival, duration of response, toxicities, and biomarkers...
  72. ncbi request reprint A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601
    Michael Findlay
    Wellington Cancer Centre, Wellington Hospital, Wellington, New Zealand
    ANZ J Surg 77:247-52. 2007
    ..With poor cure rates in gastric cancer using surgery alone, the safety, efficacy and feasibility of preoperative and postoperative chemotherapy was investigated...
  73. ncbi request reprint Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
    Malcolm J Moore
    Division of Medical Oncology, Princess Margaret Hospital, Toronto, Canada
    J Clin Oncol 25:1960-6. 2007
    ..We studied the effects of adding the HER1/EGFR-targeted agent erlotinib to gemcitabine in patients with unresectable, locally advanced, or metastatic pancreatic cancer...
  74. doi request reprint 3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome
    Nigel Spry
    Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
    Int J Radiat Oncol Biol Phys 70:1438-46. 2008
    ....
  75. ncbi request reprint A systematic review of the effect of waiting for treatment for chronic pain
    Mary E Lynch
    Department of Psychiatry and Anesthesia, Dalhousie University, Halifax, Nova Scotia, Canada
    Pain 136:97-116. 2008
    ..Most important is the need to improve access to appropriate care for patients with chronic pain, an escalating public health care problem with significant human and economic costs...
  76. ncbi request reprint A case of bipolar disorder and typhoid fever
    Christopher G Santangelo
    Department of Psychiatry, Georgetown University Hospital, Washington, DC 20007, USA
    Int J Psychiatry Med 34:267-9. 2004
    ..In this report, we summarize the biological, psychological, and social underpinnings of this rare and interesting case...
  77. doi request reprint Identification of metastasis-related microRNAs in hepatocellular carcinoma
    Anuradha Budhu
    Liver Carcinogenesis Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Hepatology 47:897-907. 2008
    ..In addition, functional analysis of these miRNAs may enhance our biological understanding of HCC metastasis...
  78. ncbi request reprint Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A response
    Samuel Y K Ngan
    ANZ J Surg 73:660-1; author reply 661-2. 2003
  79. ncbi request reprint Colorimetric evaluation of facial skin and free flap donor sites in various ethnic populations
    Kenny Ngo
    Wharton Head and Neck Centre, Department of Surgical Oncology, Otolaryngology Head and Neck Surgery, University Health Network, Princess Margaret Hospital, Toronto, Ontario
    J Otolaryngol 35:249-54. 2006
    ..To determine the optimal colour match for free tissue donor sites transferred to defects of the cheek and neck in a multicultural population...
  80. doi request reprint Genetic polymorphisms and head and neck cancer outcomes: a review
    Jessica Hopkins
    Community Medicine Residency Program and Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada
    Cancer Epidemiol Biomarkers Prev 17:490-9. 2008
    ..Despite a large number of exploratory studies, large replication studies in well-characterized HNC populations are warranted...
  81. ncbi request reprint Half of patients with obstructive sleep apnea have a higher NREM AHI than REM AHI
    Fouzia Siddiqui
    NJ Neuroscience Institute at JFK Medical Center, Seton Hall University School of Graduate Medical Education, Edison, NJ 08818 USA
    Sleep Med 7:281-5. 2006
    ..Males, as well as older individuals, are generally more predominantly affected with OSA than females. Usually OSA is worse in REM sleep than in NREM sleep, although this is not always true...
  82. ncbi request reprint Do you see what I see? The impact of age differences in time perspective on visual attention
    Ruthann C Thomas
    Department of Psychology, University of Toronto, Ontario, M5S 3G3, Canada
    J Gerontol B Psychol Sci Soc Sci 62:P247-52. 2007
    ..Consistent with views on temporal perspective and cognition ( Liberman, Sagristano, & Trope, 2002), we found that younger adults were more likely than older adults to orient toward holistic processing...
  83. ncbi request reprint Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801)
    Samuel Y K Ngan
    Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    Dis Colon Rectum 48:1389-96. 2005
    ..5 years of follow-up...
  84. pmc Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study
    Michael Steffes
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55454, USA
    Clin Chem 51:753-8. 2005
    ..Clinical trials require assays that provide consistent results during the course of a study. The hemoglobin A1c (HbA1c) assay, a measure of chronic glycemia, is critical to the study of diabetes control and complications...